175 related articles for article (PubMed ID: 187612)
1. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
New MI; Peterson RE; Saenger P; Levine LS
J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid hypertension in childhood.
New MI; Levine LS
Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586
[TBL] [Abstract][Full Text] [Related]
3. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
4. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
5. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism.
Sonino N; Levine LS; New MI
Acta Endocrinol (Copenh); 1981 Sep; 98(1):87-94. PubMed ID: 7025545
[TBL] [Abstract][Full Text] [Related]
7. Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.
Taylor AA; Mitchell JR; Bartter FC; Snodgrass WR; McMurtry RJ; Gill JR; Franklin RB
J Clin Invest; 1978 Jul; 62(1):162-8. PubMed ID: 149141
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
[TBL] [Abstract][Full Text] [Related]
10. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
[TBL] [Abstract][Full Text] [Related]
11. Hypertension of childhood with suppressed renin.
New MI; Levine LS
Endocr Rev; 1980; 1(4):421-30. PubMed ID: 6265200
[No Abstract] [Full Text] [Related]
12. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827
[TBL] [Abstract][Full Text] [Related]
13. Urinary free 18-hydroxy-11-desoxycorticosterone excretion in normal and hypertensive patients.
Agrin RJ; Dale SL; Holbrook M; LaRossa JT; Melby JC
J Clin Endocrinol Metab; 1978 Oct; 47(4):877-84. PubMed ID: 233684
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 18-hydroxydeoxycorticosterone in the rat.
Tan SY; Mulrow PJ
Endocrinology; 1978 Apr; 102(4):1113-7. PubMed ID: 217614
[TBL] [Abstract][Full Text] [Related]
15. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
Grim CE; Weinberger MH
Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
[TBL] [Abstract][Full Text] [Related]
16. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
17. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
Woodland E; Tunny TJ; Hamlet SM; Gordon RD
Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
[TBL] [Abstract][Full Text] [Related]
18. The contribution of the zona fasciculata and glomerulosa to plasma 11-deoxycorticosterone levels in man.
Tan SY; Mulrow PJ
J Clin Endocrinol Metab; 1975 Jul; 41(1):126-30. PubMed ID: 168227
[TBL] [Abstract][Full Text] [Related]
19. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
[TBL] [Abstract][Full Text] [Related]
20. Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
Ganguly A; Meikle AW; Tyler FH; West CD
J Clin Endocrinol Metab; 1977 Mar; 44(3):560-8. PubMed ID: 190262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
